Secondary prevention of sudden cardiac death

Italian Heart Journal

Volumn 6, Issue 3, 2005, Pages 216-220

  Curnis, Antonio ^a   Mascioli, Giosuè ^a   Bontempi, Luca ^a   Bordonali, Tania ^a   Cas, Livio Dei ^a  

^a Electrophysiology and Cardiostimulation Laboratory   (Italy)

Author keywords

Secondary prevention; Sudden cardiac death; Ventricular arrhythmia

Indexed keywords

ANTIARRHYTHMIC AGENT;

DEFIBRILLATOR; HEART ARRHYTHMIA; HUMAN; RECURRENT DISEASE; REVIEW; SUDDEN DEATH;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; RECURRENCE;

EID: 22344444424     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Myerburg R, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119: 1187-97.
2. Uretsky B, Thygesen K, Armstrong P, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Circulation 2000; 102: 611-6.
3. Herre JM, Sauve MJ, Malone P, et al. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989; 13: 442-9.
4. Mason JW. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study Versus Electrocardiographic Monitoring Investigators. N Engl J Med 1993; 329: 445-51.
5. The CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993; 72: 280-7.
6. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-8.
7. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.
8. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable defibrillator against amiodarone. Circulation 2000; 101: 1297-302.
9. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-54.
10. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillators secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000; 21: 2071-8.
11. Raitt MH, Renfroe EG, Epstein AE, et al, for the Antiarrhythmics Versus Implantable Defibrillators Investigators. "Stable" ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) registry. Circulation 2001; 103: 244-52.
12. Olson PJ, Woelfel A, Simpson RJ Jr, Foster JR. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol 1993; 71: 823-6.